Vimarsana
Biggest News Aggregation in the World

Validation Across News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Validation Across. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Validation Across Today - Breaking & Trending Today

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data - Vimarsana News

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data

Published: November 9, 2022

/PRNewswire/ -- Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and YonaLink, a clinical trial software...

Source: prnewswire.com
Related Topics:
United StatesOphir ShahafIddo PelegVincent LepreuxYonalink SaaIsabelle PelveHead Of CommunicationsVp Business DevelopmentCompany SaaTechnology Brings New Levels Of SpeedDebiopharm InternationalShadar GroupEuropean UnionPrnewswire Debiopharm Innovation FundHealth VenturesDebiopharm Innovation FundSaas Platform Provides Missing LinkClinical Trial Data CollectionSecurely Automating Real Time TransferUp To Date Patient Data DirectlyBrings New LevelsValidation AcrossInnovation FundAssociate DirectorDebiopharm Innovation
Debiopharm International SA: Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data - Vimarsana News

Debiopharm International SA: Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data

Published: November 9, 2022

SaaS Platform Provides Missing Link in Clinical Trial Data Collection, Securely Automating Real-Time Transfer of Up-to-Date Patient Data Directly from EHRs to EDC Systems Technology Brings

Source: finanznachrichten.de
Related Topics:
United StatesOphir ShahafKostenloser WertpapierhandelIddo PelegVincent LepreuxYonalink SaaIsabelle PelveHead Of CommunicationsVp Business DevelopmentCompany SaaTechnology Brings New Levels Of SpeedShadar GroupEuropean UnionPrnewswire Debiopharm Innovation FundHealth VenturesDebiopharm Innovation FundSaas Platform Provides Missing LinkClinical Trial Data CollectionSecurely Automating Real Time TransferUp To Date Patient Data DirectlyBrings New LevelsValidation AcrossInnovation FundAssociate DirectorDebiopharm Innovation
Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data - Vimarsana News

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data

Published: November 9, 2022

SaaS Platform Provides Missing Link in Clinical Trial Data Collection, Securely Automating Real-Time Transfer of Up-to-Date Patient Data Directly ...

Source: businessinsider.com
Related Topics:
United StatesOphir ShahafIddo PelegVincent LepreuxYonalink SaaIsabelle PelveCompany SaaTechnology Brings New Levels Of SpeedDebiopharm InternationalShadar GroupEuropean UnionOphir Shahaf Vp Business DevelopmentPrnewswire Debiopharm Innovation FundHealth VenturesDawn Bonine Head Of CommunicationsDebiopharm Innovation FundSaas Platform Provides Missing LinkClinical Trial Data CollectionSecurely Automating Real Time TransferUp To Date Patient Data DirectlyBrings New LevelsValidation AcrossInnovation FundAssociate DirectorDebiopharm Innovation
Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data - Vimarsana News

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data

Published: November 9, 2022

/PRNewswire/ -- Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and YonaLink, a clinical trial software...

Source: prnewswire.com
Related Topics:
United StatesOphir ShahafIddo PelegVincent LepreuxYonalink SaaIsabelle PelveHead Of CommunicationsVp Business DevelopmentCompany SaaTechnology Brings New Levels Of SpeedDebiopharm InternationalShadar GroupEuropean UnionPrnewswire Debiopharm Innovation FundHealth VenturesDebiopharm Innovation FundSaas Platform Provides Missing LinkClinical Trial Data CollectionSecurely Automating Real Time TransferUp To Date Patient Data DirectlyBrings New LevelsValidation AcrossInnovation FundAssociate DirectorDebiopharm Innovation
Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data - Vimarsana News

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data

Published: November 9, 2022

/PRNewswire/ -- Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and YonaLink, a clinical trial software...

Source: prnewswire.com
Related Topics:
United StatesOphir ShahafIddo PelegVincent LepreuxYonalink SaaIsabelle PelveHead Of CommunicationsVp Business DevelopmentCompany SaaTechnology Brings New Levels Of SpeedDebiopharm InternationalShadar GroupEuropean UnionPrnewswire Debiopharm Innovation FundHealth VenturesDebiopharm Innovation FundSaas Platform Provides Missing LinkClinical Trial Data CollectionSecurely Automating Real Time TransferUp To Date Patient Data DirectlyBrings New LevelsValidation AcrossInnovation FundAssociate DirectorDebiopharm Innovation